v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development expense $ 23,485 $ 12,100 $ 47,189 $ 32,280
General and administrative 7,367 5,228 15,125 10,173
Total operating expenses 30,852 17,328 62,314 42,453
Loss from operations (30,852) (17,328) (62,314) (42,453)
Other income (expense), net:        
Interest income 4,573 2,910 9,092 5,277
Change in fair value of contingent value right liability 0 (1,500) 0 (1,500)
Other expense (13) (5) (14) (5)
Total other income (expense), net 4,560 1,405 9,078 3,772
Loss before income taxes (26,292) (15,923) (53,236) (38,681)
Income tax expense (60) (24) (65) (47)
Net loss (26,352) (15,947) (53,301) (38,728)
Net loss attributable to common stockholders-basic (26,352) (15,947) (53,301) (38,728)
Net loss attributable to common stockholders-diluted $ (26,352) $ (15,947) $ (53,301) $ (38,728)
Weighted-average common shares outstanding-basic 25,649,043 21,484,955 25,229,456 20,226,923
Weighted-average common shares outstanding-diluted 25,649,043 21,484,955 25,229,456 20,226,923
Net loss per share attributable to common stockholders-basic $ (1.03) $ (0.74) $ (2.11) $ (1.91)
Net loss per share attributable to common stockholders-diluted $ (1.03) $ (0.74) $ (2.11) $ (1.91)
Comprehensive loss:        
Net loss $ (26,352) $ (15,947) $ (53,301) $ (38,728)
Other comprehensive loss:        
Foreign currency translation adjustments 6 0 6 0
Unrealized loss on marketable securities (66) 0 (66) 0
Total other comprehensive loss (60) 0 (60) 0
Comprehensive loss $ (26,412) $ (15,947) $ (53,361) $ (38,728)